Lucas Ward
Stock Analyst at Ascendiant Capital
(0.43)
# 3,927
Out of 4,820 analysts
15
Total ratings
26.67%
Success rate
-44.5%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $2.64 | +134.85% | 3 | Apr 15, 2025 | |
| LIQT LiqTech International | Reiterates: Buy | $3.2 → $3.4 | $1.59 | +113.85% | 4 | Apr 7, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.62 | +286.74% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $6.75 | +7,025.93% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $5.88 | +45,818.37% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $144 | $2.53 | +5,591.70% | 1 | Oct 2, 2023 |
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $2.64
Upside: +134.85%
LiqTech International
Apr 7, 2025
Reiterates: Buy
Price Target: $3.2 → $3.4
Current: $1.59
Upside: +113.85%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.62
Upside: +286.74%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $6.75
Upside: +7,025.93%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $5.88
Upside: +45,818.37%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $144
Current: $2.53
Upside: +5,591.70%